{
    "2019-03-31": [
        [
            {
                "time": "",
                "original_text": "创新疫苗将进入第二波浪潮，重新梳理长期医药十年十倍四大主线【国盛医药张金洋团队】",
                "features": {
                    "keywords": [
                        "创新疫苗",
                        "第二波浪潮",
                        "长期医药",
                        "十年十倍",
                        "四大主线"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "西南证券：心有猛虎 细嗅蔷薇",
                "features": {
                    "keywords": [
                        "西南证券",
                        "心有猛虎",
                        "细嗅蔷薇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞市值涨超400亿 11家药企跌出500强",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "市值涨超400亿",
                        "药企",
                        "跌出500强"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗去年净利12.19亿同比增长36% 董事长蒲忠杰未在公司领取报酬",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "净利12.19亿",
                        "同比增长36%",
                        "董事长",
                        "未领取报酬"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}